semaglutide and colon cancer GLP-1 drugs cancer: the headline is exciting. The full picture is more nuanced. New research from @ascocancer 2026 shows patients on GLP-1 medications like were up to 50% less likely Mounjaro and Colon Cancer: Evidence,

Manufactured by Novo Nordisk, semaglutide is a GLP-1 receptor agonist (glucagon-like peptide-1) that is used to improve blood sugar control (Ozempic and Rybelsus) in individuals with type 2 diabetes mellitus and to support chronic weight management (Wegovy) in individuals who are obese or overweight

He also continued to see a therapist he had been going to for years for additional support in his weight loss journey

The dual action means Tirzepatide not only reduces appetite but might also have an additional effect on how the body handles blood sugar and stores fat

Eye problems: Mounjaro can worsen diabetic eye conditions, particularly if you have a history of diabetic retinopathy